Augusto Consoli

Specialization: Psychiatrist
40 years of experience
Speaks:
English, Italian
Online consultations: available
Workplace: Italy, Bologna, Lucia Magnani Health Clinic
Specialist in psychiatry and addiction treatment, expert in training and clinical and organizational supervision. Medical director of the Project conducted at the Caterina da Siena Hospital for Transcranial Magnetic Stimulation and Neuromodulation. President of the Italian Scientific Society for the Study of Pathological Addictions (SITD).
Dr. Augusto Consoli is a medical professional specializing in Psychotherapy. He has significantly contributed to the field of opioid addiction treatment through his research work, particularly a study on the safety and effectiveness of levomethadone.

Online consultation with Augusto Consoli

Convenient and easy

100% secure and confidential

Price on request

Doctor's services

How are we doing?

1 of 3

Information about this doctor is full and clear

Strongly agree

Strongly disagree

Qualifications

Dr. Augusto Consoli has demonstrated his dedication and expertise in the field of Psychotherapy, with a particular focus on opioid addiction treatment. His significant contribution to a prospective study on the safety and effectiveness of levomethadone showcases his commitment to advancing medical knowledge and patient care.

Research Contributions

Played a crucial role in an observational, prospective study focusing on the safety and effectiveness of levomethadone in subjects undergoing opioid maintenance treatment (LEVOPROACT study).
Contributed to the study design, data collection, and interpretation.
Participated in manuscript writing, editing, and approval for submission.
Collaborated with principal investigators from various participant centers across Italy.

Study Findings

The study evaluated the safety profile of levomethadone, particularly its effects on the QT interval on an electrocardiogram, and its effectiveness in reducing craving and opioid use.
The interim analysis of the study yielded encouraging preliminary results, showing effectiveness of treatment with a favorable risk/benefit ratio for levomethadone therapy.